Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

S&P Pharmaceuticals SPDR (XPH)

S&P Pharmaceuticals SPDR (XPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
Trade XPH with:
  • Price/Earnings ttm 10.54
  • Annual Dividend & Yield 0.59 (1.44%)
  • Most Recent Dividend 0.173 on 03/18/24
  • Management Fee 0.35%
  • Sectors:

    ETFs - Biotech

Options Overview Details

View History
  • Implied Volatility 6.35% ( -9.38%)
  • Historical Volatility 16.00%
  • IV Percentile 0%
  • IV Rank 0.00%
  • IV High 24.64% on 08/21/23
  • IV Low 6.35% on 05/20/24
  • Put/Call Vol Ratio 35.00
  • Today's Volume 36
  • Volume Avg (30-Day) 23
  • Put/Call OI Ratio 1.21
  • Today's Open Interest 496
  • Open Int (30-Day) 422

Price Performance

See More
Period Period Low Period High Performance
1-Month
38.89 +6.15%
on 04/25/24
41.70 -1.01%
on 05/15/24
+2.14 (+5.47%)
since 04/19/24
3-Month
38.88 +6.17%
on 04/19/24
45.62 -9.51%
on 02/27/24
-3.20 (-7.19%)
since 02/20/24
52-Week
34.67 +19.06%
on 11/13/23
45.62 -9.51%
on 02/27/24
+0.59 (+1.45%)
since 05/19/23

Most Recent Stories

More News
How Much Pain Will Lower Medicare Prices Cause for Pharma Stocks?

Pharmaceutical stocks are holding steady as Medicare price negotiations approach, but industry diversification and innovation support future growth prospects.

AMGN : 314.54 (+0.66%)
BMY : 43.36 (-1.52%)
LLY : 783.18 (+1.71%)
XLV : 146.00 (-0.21%)
HZNP : 116.30 (+0.04%)
JNJ : 151.27 (-1.39%)
MRK : 130.99 (-0.15%)
NVS : 102.84 (+0.26%)
NVO : 132.91 (+0.77%)
XPH : 41.28 (+0.26%)
ALPMY : 9.6400 (+1.69%)
Pharma ETFs Gain Post Q1 Earnings

Many industry bigwigs reported solid results, with some beating on earnings or revenues or both. As such, pharma ETFs have been in the green over the past month.

JNJ : 151.27 (-1.39%)
PJP : 80.80 (-0.06%)
IHE : 66.17 (+0.15%)
XPH : 41.28 (+0.26%)
PPH : 90.31 (+0.09%)
FTXH : 27.14 (-0.09%)
Should You Invest in the SPDR S&P Pharmaceuticals ETF (XPH)?

Sector ETF report for XPH

XPH : 41.28 (+0.26%)
MRK : 130.99 (-0.15%)
AXSM : 77.58 (+1.36%)
IHE : 66.17 (+0.15%)
PPH : 90.31 (+0.09%)
HRMY : 29.72 (+2.38%)
Is SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now?

Smart Beta ETF report for XPH

XPH : 41.28 (+0.26%)
MRK : 130.99 (-0.15%)
AXSM : 77.58 (+1.36%)
IHE : 66.17 (+0.15%)
PPH : 90.31 (+0.09%)
HRMY : 29.72 (+2.38%)
A Look at Pharma ETFs Post Q4 Earnings

Combining the actual results with the estimates for the still-to-report companies, total earnings for the healthcare sector are expected to decline 9% on revenue growth of 4.3%.

BMY : 43.36 (-1.52%)
JNJ : 151.27 (-1.39%)
PFE : 28.53 (-0.38%)
MRK : 130.99 (-0.15%)
LLY : 783.18 (+1.71%)
PJP : 80.80 (-0.06%)
IHE : 66.17 (+0.15%)
XPH : 41.28 (+0.26%)
PPH : 90.31 (+0.09%)
FTXH : 27.14 (-0.09%)
Is SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now?

Smart Beta ETF report for XPH

XPH : 41.28 (+0.26%)
MRK : 130.99 (-0.15%)
AXSM : 77.58 (+1.36%)
IHE : 66.17 (+0.15%)
PPH : 90.31 (+0.09%)
HRMY : 29.72 (+2.38%)
Should You Invest in the SPDR S&P Pharmaceuticals ETF (XPH)?

Sector ETF report for XPH

XPH : 41.28 (+0.26%)
MRK : 130.99 (-0.15%)
AXSM : 77.58 (+1.36%)
IHE : 66.17 (+0.15%)
PPH : 90.31 (+0.09%)
HRMY : 29.72 (+2.38%)
Amgen to Buy Horizon Therapeutics: ETFs to Bet On

Amgen (AMGN) has agreed to buy Horizon Therapeutics PLC (HZNP) for $27.8 billion. This put the spotlight on pharma ETFs, which could be the best way for investors to tap the opportunity arising from the...

AMGN : 314.54 (+0.66%)
HZNP : 116.30 (+0.04%)
PJP : 80.80 (-0.06%)
IHE : 66.17 (+0.15%)
XPH : 41.28 (+0.26%)
PPH : 90.31 (+0.09%)
FTXH : 27.14 (-0.09%)
Is SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now?

Smart Beta ETF report for XPH

XPH : 41.28 (+0.26%)
NKTR : 1.7500 (-0.28%)
CORT : 28.88 (+2.81%)
AXSM : 77.58 (+1.36%)
IHE : 66.17 (+0.15%)
PPH : 90.31 (+0.09%)
Pharma ETFs in Focus Post Q3 Earnings

The Q3 earnings picture for the healthcare sector seems solid, with results from companies that have reported so far up 2.1% on 5.8% revenue growth.

PJP : 80.80 (-0.06%)
IHE : 66.17 (+0.15%)
XPH : 41.28 (+0.26%)
PPH : 90.31 (+0.09%)
FTXH : 27.14 (-0.09%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Fund Summary

The SPDR SP Pharmaceuticals ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the SP Pharmaceuticals Select Industry Index.

See More

Key Turning Points

3rd Resistance Point 41.68
2nd Resistance Point 41.55
1st Resistance Point 41.42
Last Price 41.28
1st Support Level 41.16
2nd Support Level 41.03
3rd Support Level 40.90

See More

52-Week High 45.62
Fibonacci 61.8% 41.44
Last Price 41.28
Fibonacci 50% 40.15
Fibonacci 38.2% 38.85
52-Week Low 34.67

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar